Locations
Vancouver, BC, Canada
industry
Biotechnology · DeepTech
Size
51-200 employees
Stage
Series B
founded in
2013
Aspect Biosystems is a Canadian biotechnology company pioneering the development of bioprinted tissue therapeutics. Their transformative platform technology integrates proprietary bioprinting, therapeutic cells, biomaterials, and computational design to create allogeneic tissue therapeutics aimed at replacing damaged organ functions. The company collaborates with leading pharmaceutical and biotech firms to address significant challenges in regenerative medicine, positioning itself as a key player in the field. With a diverse team of innovators, Aspect has raised over $200M in capital and is focused on delivering groundbreaking solutions for currently incurable diseases.
Something looks off?On-site & Remote